FDA Label for Over-the-Counter Naloxone. Reply

N Engl J Med. 2020 Sep 10;383(11):1093. doi: 10.1056/NEJMc2023426.

Authors

Barbara R Cohen¹, Elande Baro¹, Amanda Pike-McCrudden¹

Affiliation

¹ Food and Drug Administration, White Oak, MD barbara.r.cohen@fda.hhs.gov.

PMID: 32905692
DOI: 10.1056/NEJMc2023426

No abstract available

Publication types

Letter
Comment

MeSH terms

Naloxone*
Narcotic Antagonists
Nonprescription Drugs*
Product Labeling

Substances

Narcotic Antagonists
Nonprescription Drugs
Naloxone